Crsp stock forecast 2025.

We feed our Machine Learning (AI based) forecast algorithm data from the most influential global exchanges. There are a number of existing AI-based platforms that try to predict the future of Stock markets. They include data research on historical volume, price movements, latest trends and compare it with the real-time performance of the market.Get a real-time CRISPR Therapeutics AG (CRSP) stock price quote with breaking news, financials, statistics, charts and more.CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).Apr 14, 2022 · The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ... In January 2025 analysts predict a stock price of $33.02. An increase of 13.4% compared to the previous month's estimate. C3.ai Stock Predictions for Feb 2025. ... Stock Forecast for the Price of an C3.ai Share in Dec 2030. In December 2030, analysts believe the stock price will be $61.87. An increase of 112.45% compared to the previous …

Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Jun 6, 2021 · For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.

Nov 17, 2022 · With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics ( CRSP -6.39%) and Bluebird Bio ( BLUE -4.44%). These ... Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...Analyzing the anticipated performance of CRISPR Therapeutics, the ceiling value that the stock is expected to reach in 2025 stands at a promising $75.1. Indicating a bullish trend, an upside potential of 67.9% signals profitable prospects, with an average monthly return of 2.61% , beckoning investors to consider amplifying their portfolios.12/02/2023. Microsoft stock price stood at $374.51. According to the latest long-term forecast, Microsoft price will hit $400 by the end of 2023 and then $500 by the end of 2025. Microsoft will rise to $600 within the year of 2026, $700 in 2028, $800 in 2030, $900 in 2033 and $1000 in 2035.

CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. CRSP updated stock price target summary.

Price target in 14 days: 83.058 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP exchange price projections: monthly and daily opening, closing, maximum and minimum stock price outlook with smart technical analysis. Markets.

On Friday, right after Thanksgiving Day, shares opened at $111.08, the stock price hovered over $120 to a new high of $124.43 before closing at $121.55 – a good 10.5% gain from the previous ...The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price.Next reporting date. February 13, 2024. EPS forecast (this quarter) -$0.20. Annual revenue (last year) $185.3M. Annual profit (last year) -$200.2M. Net profit margin.Dec 1, 2023 · According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy. Despite the pain today, there are a handful of Cathie Wood stocks that could double by 2025. Here are three of them. Despite the pain today, there are a handful of intriguing Cathie Wood stocks Source: rhendrikdwenz via Shutterstock It’s be...Detailed Monthly CRISPR Therapeutics (CRSP) Stock Forecast and Prediction for 2025 In the fast-paced biotech industry, forecasting stock performance is a mix of art and science. As we enter 2025, the journey of CRISPR Therapeutics’ stock stands at an intriguing crossroads.

Traders Union experts conducted a comprehensive analysis and predicted that by the end of 2024 Google price will hit $179.92. Google will grow to $200.9 in 2025, $279.67 in 2028 and $348.68 in 2030. Traders Union analysts have prepared a selection of analytical forecasts from top portals for 2024, 2025, 2030.Tesla Stock Forecast 2023, 2024, 2025. Apple stock predictions for January 2025. The forecast for beginning of January 275. Maximum value 293, while minimum 259. Averaged Apple stock price for month 276. Price at the end 276, change for January 0.36%. Apple stock price predictions for February 2025.VGT Analyst Price Target. $505.02. Based on 320 Wall Street analysts offering 12 month price targets to VGT holdings in the last 3 months. The average price target is $505.02 with a high forecast of $613.93 and a low forecast of $406.59. The average price target represents a 9.70% change from the last price of $460.37.Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. Price Prediction forecast forCRISPR Therapeutics to November 26, and an in-depth analysis for the week of 19 November to 2 December.According to our current UPST stock forecast, the value of Upstart Holdings shares will drop by -21.59% and reach $ 24.43 per share by December 6, 2023. According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).UPST stock recorded 12/30 (40%) green days with 9.94% price volatility over …Nov 19, 2023 · CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...

Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …Lithium Americas stock prediction for December 2024. In the beginning at 5.79. Maximum 6.00, minimum 5.12. The averaged price 5.62. At the end of the month 5.56 dollars, change for December -4.0%. Lithium Americas stock price forecast for January 2025. In the beginning at 5.56. Maximum 6.43, minimum 5.47.See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ... That success has led to dramatic price increases for CRSP stock since going public in 2016. Shares flirted with the $200 level in 2021 during the most recent market peak. They currently trade for ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the AbCellera Biologics share forecasts, stock quote and buy / sell signals below. According to present data AbCellera Biologics's ABCL shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Stock Price Forecast. The 22 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 81.00, with a high estimate of 220.00 and a low estimate of 42.00. The median estimate represents a +17.27% increase from the …

Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (CRSP-6.39%), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from … See more

MERCERWISE 2025 TARGET DATE C- Performance charts including intraday, historical charts and prices and keydata. Indices Commodities Currencies Stocks

Nov 30, 2023 · Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ... Nov 14, 2023 · The share price of CRISPR Therapeutics AG (CRSP) now. What analysts predict: $88.13. 52-week High/Low: $72 / $37.55. 50/200 Day Moving Average: $45.85 / $51.4. This figure corresponds to the Average Price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the support level today. Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.That's an eye catching number but take a step back and think about it. We hit $5.00 last week. If it doubles in 2021 that's $10.00 and if it doubles again in 2 years by 2023 that's $20.00 leaving 2024 for 30% growth to 26.00. In a growing EV market, with a fully differentiated product.AT&T Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 16.48. Negative dynamics for AT&T shares will prevail with possible volatility of 1.632%. Pessimistic target level: 16.40. Optimistic target level: 16.67.Nov 17, 2022 · With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics ( CRSP -6.39%) and Bluebird Bio ( BLUE -4.44%). These ... CRISPR Therapeutics Stock Up 14.6 %. NASDAQ:CRSP opened at $67.89 on Friday. The company’s 50 day moving average price is $46.64 and its 200-day moving average price is $53.09. CRISPR Therapeutics has a 52 week low of $37.55 and a 52 week high of $72.00. The stock has a market cap of $5.39 billion, a price-to-earnings ratio of -15.19 and a ...Competitors. The 26 analysts offering 12-month price forecasts for Halliburton Co have a median target of 49.50, with a high estimate of 56.00 and a low estimate of 44.00. The median estimate ...CRSP - CRISPR Therapeutics Stock Prediction 2025 - 2030 + Portfolio 7 years of reliable CRISPR Therapeutics stock forecast. The Wall Street analysts predict Outperform for CRSP. See at a glance whether NasdaqGM:CRSP will rise in the future. $41.47 Forecast 2023 $49.60 Forecast 2025 $77.58 Forecast 2030 Underperform TopGraphs Quality RankingUpgrade: " Piper Sandler analyst Edward Tenthoff with an overweight recommendation and $180 per share target on CRISPR (CRSP), urges investors to buy the dip. Tenthoff argues that data “validate CTX110 and CRISPR’s allogeneic CAR-T pipeline” with the company planning to expand the study." I agree with this guy!:-) 6.Nov 21, 2023 · The weighted average target price per CRISPR Therapeutics share in Dec 2023 is: 68.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 15.330% volatility is expected. CRISPR Therapeutics stock price predictions for 2023 using artificial intelligence. Nov 17, 2022 · With that in mind, let's look at two gene-editing-focused biotechs that could perform substantially better next year: CRISPR Therapeutics ( CRSP -6.39%) and Bluebird Bio ( BLUE -4.44%). These ...

CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.Oct 27, 2023 · Unraveling CRISPR Therapeutics (CRSP) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing CRISPR Therapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 28, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics …NVIDIA Corporation Common Stock. $408.22 -2.95 0.72%. MULN. Mullen Automotive, Inc. Common Stock. $0.116 +0.0059 5.36%. Find the latest analyst research for CRISPR Therapeutics AG Common Shares ...Instagram:https://instagram. lowest spread forex brokersxyld stock priceself employed dental coveragenvda price targets CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).Wall Street Stock Market & Finance report, prediction for the future: You'll find the Salesforce share forecasts, stock quote and buy / sell signals below. According to present data Salesforce's CRM shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). vangaurd bond etfforex sites As always, investors should be on the lookout, although it seems unlikely that Facebook or any of the company’s other brands would disappear. Long-term projections have Meta at $272 by the end of 2022 and $360 by the end of 2023. Meta stock will hit $470 in 2025, $580 in 2027, and $765 in 2030, with further gains expected thereafter. … options trading game Detailed Monthly CRISPR Therapeutics (CRSP) Stock Forecast and Prediction for 2025 In the fast-paced biotech industry, forecasting stock performance is a mix of art and science. As we enter 2025, the journey of CRISPR Therapeutics’ stock stands at an intriguing crossroads.Nov 30, 2023 · Based on short-term price targets offered by 22 analysts, the average price target for CRISPR Therapeutics AG comes to $89.77. The forecasts range from a low of $42.00 to a high of $220.00. The ... The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis. Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. ... 2025 January: 2025 January 01, Wednesday: 14.541: 12.35985: 16.72215: 2025 January …